Cashen A - Search Results

1

A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia.

Wartman LD, Fiala MA, Fletcher T, Hawkins ER, Cashen A, DiPersio JF, Jacoby MA, Stockerl-Goldstein KE, Pusic I, Uy GL, Westervelt P, Vij R. Wartman LD, et al. Among authors: cashen a. Leuk Lymphoma. 2016;57(3):728-30. doi: 10.3109/10428194.2015.1076930. Epub 2015 Oct 5. Leuk Lymphoma. 2016. PMID: 26674111 Free PMC article. Clinical Trial. No abstract available.

2

Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?

Cashen A, DiPersio JF, Khoury H. Cashen A, et al. J Clin Oncol. 2003 Nov 15;21(22):4255-6. doi: 10.1200/JCO.2003.99.209. J Clin Oncol. 2003. PMID: 14615462 No abstract available.

3

Cytokines and stem cell mobilization for autologous and allogeneic transplantation.

Cashen AF, Link D, Devine S, DiPersio J. Cashen AF, et al. Curr Hematol Rep. 2004 Nov;3(6):406-12. Curr Hematol Rep. 2004. PMID: 15496273 Review.

4

Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine.

Cashen AF, Devine H, DiPersio J. Cashen AF, et al. Am J Hematol. 2006 Jul;81(7):543-5. doi: 10.1002/ajh.20626. Am J Hematol. 2006. PMID: 16755561 Free article.

5

AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent.

Cashen AF, Nervi B, DiPersio J. Cashen AF, et al. Future Oncol. 2007 Feb;3(1):19-27. doi: 10.2217/14796694.3.1.19. Future Oncol. 2007. PMID: 17280498

6

Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

Cashen AF, Shah AK, Todt L, Fisher N, DiPersio J. Cashen AF, et al. Cancer Chemother Pharmacol. 2008 Apr;61(5):759-66. doi: 10.1007/s00280-007-0531-7. Epub 2007 Jun 13. Cancer Chemother Pharmacol. 2008. PMID: 17564707 Clinical Trial.

7

Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF. Pusic I, et al. Biol Blood Marrow Transplant. 2008 Sep;14(9):1045-1056. doi: 10.1016/j.bbmt.2008.07.004. Biol Blood Marrow Transplant. 2008. PMID: 18721768 Free article.

8

Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.

Uy GL, Rettig MP, Cashen AF. Uy GL, et al. Expert Opin Biol Ther. 2008 Nov;8(11):1797-804. doi: 10.1517/14712598.8.11.1797. Expert Opin Biol Ther. 2008. PMID: 18847313 Review.

9

A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.

Cashen A, Lopez S, Gao F, Calandra G, MacFarland R, Badel K, DiPersio J. Cashen A, et al. Biol Blood Marrow Transplant. 2008 Nov;14(11):1253-61. doi: 10.1016/j.bbmt.2008.08.011. Biol Blood Marrow Transplant. 2008. PMID: 18940680 Free article. Clinical Trial.

10

Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.

Martin MG, Uy GL, Procknow E, Stockerl-Goldstein K, Cashen A, Westervelt P, Abboud CN, Augustin K, Luo J, DiPersio JF, Vij R. Martin MG, et al. Among authors: cashen a. Bone Marrow Transplant. 2009 Jul;44(1):13-7. doi: 10.1038/bmt.2008.423. Epub 2009 Jan 12. Bone Marrow Transplant. 2009. PMID: 19139740 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters